Daniel R. Zweitzig
Research Subjects
Research Interests
Daniel R. Zweitzig has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mark J. Kopnitsky
ZEUS Scientific Inc., 200 Evans Way, Branchburg, NJ 08876, United States
4 shared publicationsArjan G. Tibbe
Department of Research & Development, VyCAP, Hallenweg 23, 7522 NH Enschede, The Netherlands
2 shared publicationsKathleen Cichonski
ZEUS Scientific Inc., 200 Evans Way, Branchburg, NJ 08876, United States
2 shared publications- Leonardus Wendelinus Mathias Marie Terstappen
Department of Medical Cell BioPhysics, Faculty of Science and Technology University of Twente Enschede The Netherlands
2 shared publications Nichol M. Riccardello
Research and Development ZEUS Scientific Raritan New Jersey
2 shared publicationsAi T. Nguyen
Aquamarijn Micro Filtration B.V., Ijsselkade 7, 7201 HB Zutphen, The Netherlands
1 shared publication
Latest Publications
- 1 August 2017
- Published by Elsevier in Journal of Immunological Methods
- Vol. 447, 86-91
Distinguishing septic from normal donors by detection of sPLA2-IIA from human plasma using a microsieve-based immunoassay
- 1 August 2017
- Published by Elsevier in Journal of Immunological Methods
- Vol. 447, 86-91
Distinguishing septic from normal donors by detection of sPLA2-IIA from human plasma using a microsieve-based immunoassay
- 1 October 2016
- Published by Elsevier in Journal of Immunological Methods
- Vol. 437, 21-27
Feasibility of a simple microsieve-based immunoassay platform
- 1 October 2016
- Published by Elsevier in Journal of Immunological Methods
- Vol. 437, 21-27
Feasibility of a simple microsieve-based immunoassay platform
- Open Access
- 5 November 2013
- Published by Wiley in Transfusion
- Vol. 54 (6) , 1642-1651
A novel approach for rapid detection of bacterially contaminated platelet concentrates via sensitive measurement of microbial DNA polymerase activity
- 5 November 2013
- Published by Wiley in Transfusion
- Vol. 54 (6) , 1642-1651
Open AccessA novel approach for rapid detection of bacterially contaminated platelet concentrates via sensitive measurement of microbial DNA polymerase activity
- Open Access
- 14 October 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e78488
Measurement of Microbial DNA Polymerase Activity Enables Detection and Growth Monitoring of Microbes from Clinical Blood Cultures
Surveillance of bloodstream infections (BSI) is a high priority within the hospital setting. Broth-based blood cultures are the current gold standard for detecting BSI, however they can require lengthy incubation periods prior to detection of positive samples. We set out to demonstrate the feasibility of using enzymatic template generation and amplification (ETGA)-mediated measurement of DNA polymerase activity to detect microbes from clinical blood cultures. In addition to routine-collected hospital blood cultures, one parallel aerobic blood culture was collected and immediately refrigerated until being transported for ETGA analysis. After refrigeration holding and transport, parallel-collected cultures were placed into a BACTEC incubator and ETGA time-course analysis was performed. Of the 308 clinical blood cultures received, 22 were BACTEC positive, and thus were initially selected for ETGA time course analysis. The ETGA assay detected microbial growth in all 22 parallel-positive blood cultures in less time than a BACTEC incubator and also yielded genomic DNA for qPCR-based organism identification. In summary, feasibility of detecting microbes from clinical blood culture samples using the ETGA blood culture assay was demonstrated. Additional studies are being considered towards development of clinically beneficial versions of this methodology.
- 14 October 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e78488
Open AccessMeasurement of Microbial DNA Polymerase Activity Enables Detection and Growth Monitoring of Microbes from Clinical Blood Cultures
Surveillance of bloodstream infections (BSI) is a high priority within the hospital setting. Broth-based blood cultures are the current gold standard for detecting BSI, however they can require lengthy incubation periods prior to detection of positive samples. We set out to demonstrate the feasibility of using enzymatic template generation and amplification (ETGA)-mediated measurement of DNA polymerase activity to detect microbes from clinical blood cultures. In addition to routine-collected hospital blood cultures, one parallel aerobic blood culture was collected and immediately refrigerated until being transported for ETGA analysis. After refrigeration holding and transport, parallel-collected cultures were placed into a BACTEC incubator and ETGA time-course analysis was performed. Of the 308 clinical blood cultures received, 22 were BACTEC positive, and thus were initially selected for ETGA time course analysis. The ETGA assay detected microbial growth in all 22 parallel-positive blood cultures in less time than a BACTEC incubator and also yielded genomic DNA for qPCR-based organism identification. In summary, feasibility of detecting microbes from clinical blood culture samples using the ETGA blood culture assay was demonstrated. Additional studies are being considered towards development of clinically beneficial versions of this methodology.
- Open Access
- 13 August 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 191
Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
Background: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum inhibitory concentrations (MICs). The present study demonstrates that measurement of DNA polymerase activity via Enzymatic Template Generation and Amplification (ETGA) can be used as a novel means of determining the MIC of a microbe to an antibiotic agent much sooner than the current standardized method. Methods: Time course analysis of ETGA is presented from bacterial cultures containing antibiotic agents and compared to the end-point results of standard macrobroth method AST. Results: MIC determinations from ETGA results at 4, 6, and 22 hours are compared to the MICs from the standard method and the results are shown to be in agreement. Additionally, reliable AST analysis using ETGA can be performed on bacteria harvested directly from spiked blood cultures. Conclusions: AST analysis with ETGA is shown to be equivalent to AST analysis using gene-specific qPCR assays against the measured microbe. Future development of this novel method for performing AST in a clinical setting is discussed.
- 13 August 2013
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 191
Open AccessFeasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
Background: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum inhibitory concentrations (MICs). The present study demonstrates that measurement of DNA polymerase activity via Enzymatic Template Generation and Amplification (ETGA) can be used as a novel means of determining the MIC of a microbe to an antibiotic agent much sooner than the current standardized method. Methods: Time course analysis of ETGA is presented from bacterial cultures containing antibiotic agents and compared to the end-point results of standard macrobroth method AST. Results: MIC determinations from ETGA results at 4, 6, and 22 hours are compared to the MICs from the standard method and the results are shown to be in agreement. Additionally, reliable AST analysis using ETGA can be performed on bacteria harvested directly from spiked blood cultures. Conclusions: AST analysis with ETGA is shown to be equivalent to AST analysis using gene-specific qPCR assays against the measured microbe. Future development of this novel method for performing AST in a clinical setting is discussed.